Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Impact of a Specific Training Program on the Neuromodulation of Pain in Fibromyalgia Subjects (DOUFISPORT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02486965
Recruitment Status : Recruiting
First Posted : July 1, 2015
Last Update Posted : January 18, 2019
Sponsor:
Information provided by (Responsible Party):
University Hospital, Brest

Brief Summary:

Fibromyalgia affects 1.4 now 2.2% of the general population whose symptom is the presence of widespread pain in all four quadrants of the body. Currently, there is no causal treatment of fibromyalgia syndrome.

The aim of this study is the evaluation of a specific training program on controls of pain in fibromyalgia patients by balancing the stress axis.

The primary endpoint is the improvement in the Visual Analogue Scale VAS difference) measured during the test of the thermode (difference between the average VAS measured between the 10th and 40th second of P1 and the average VAS measured between the 10th and 40th of the second P3) between D0 (3rd consultation) and M24 (5th consultation - end of study visit), which will be compared in the two groups..Salivary cortisol is also tested.


Condition or disease Intervention/treatment Phase
Fibromyalgia Device: thermode (TSA-II model) Other: Adapted Physical Activity Other: Physical activity Not Applicable

Detailed Description:

A specific training program under the guidance of a physiotherapist, a professor of Adapted Physical Activity (APA) and individualized whose objective is to strengthen the parasympathetic tone and modulate the reactivity of the sympathetic system and the report of the Hypothalamic-Pituitary-Adrenal (HPA) axis.This training program consists of three sessions of 45 minutes of physical activity per week for 2 years. The exercise intensity is initially very low and will be gradually increased according to your abilities and your tolerance to stress. A 6-Minute Walk Test (6MWT) will be carried out by the physiotherapist and by Professor APA, every 6 months to monitor the progression. For tracking the training program, a phone call is scheduled every week during the first 3 months, then a phone call every 15 days during the following months until the end of the study.Evaluation of neuromodulation of pain will be measured thanks to thermodeTest , experimental method implementing a tonic thermal pain using a "Peltier type Thermode" 3 cm2 model TSA II and immersion in a bath of cold water.

Participants will be randomly assigned to 2 groups, "Training" group or "Control" group.

The control group is a training program supervised by physical therapists and teachers in Adapted Physical Activity, identical to the active program in its follow-up, but the intensity of the sessions is lower.

Study schedule :

  • 1st visit : screening visit at D-30
  • 2nd visit : inclusion at D-7
  • 3rd visit at D0
  • 4st visit between M6 and M9
  • 5th visit at M24

The patients included in the study will receive in addition to the training program, taking into bio-psycho-social multidisciplinary.


Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 110 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Supportive Care
Official Title: Impact of a Specific Training Program on the Neuromodulation of Pain in Fibromyalgia Subjects
Study Start Date : October 2015
Estimated Primary Completion Date : October 2019
Estimated Study Completion Date : October 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Fibromyalgia

Arm Intervention/treatment
Experimental: training group

The training program consists of three sessions of 45 minutes of physical activity per week for 2 years. During the first 6-9 months, two individual workouts, supervised by a physiotherapist and a session in Living.

Depending on the capacity and exercise tolerance of the patient, patients realize the second phase of training until 2 years of the study: three exercise sessions from 45 to 60 minutes per week of which group session led by a professor of Adapted Physical Activity (APA) and 2 autonomous sessions.

Thermal stimulation with test thermode Thermic stimulations (tonic heat pain stimulation and cold-pressor test) are used to test excitatory and inhibitory pain mechanisms

Device: thermode (TSA-II model)
thermal stimulation with test thermode

Other: Adapted Physical Activity
Other: Physical activity
Placebo Comparator: control group
A training program supervised by physical therapists and teachers in Adapted Physical Activity, identical to the active program in its follow-up, but the intensity of the sessions is lower than that of the training group
Other: Adapted Physical Activity



Primary Outcome Measures :
  1. Pain as assessed by Visual analog scale [ Time Frame: baseline to 24 months ]

Secondary Outcome Measures :
  1. salivary cortisol [ Time Frame: baseline to 24 months ]
    three times : 3th visit at Day 0, 4th visit between month 6 and 9, 5th visit at month 24

  2. heart rate variability [ Time Frame: baseline to 24 months ]
    three times : 2th visit at Day -7, 4th visit between month 6 and 9, 5th visit at month 24

  3. Fibromyalgia Impact Questionnaire (FIQ) [ Time Frame: baseline to 24 months ]
  4. Hospital Anxiety Depression Scale (HADS) [ Time Frame: baseline to 24 months ]
  5. Pressure Pain Threshold (PSS) [ Time Frame: baseline to 24 months ]
  6. International Physical Activity Questionnaire (IPAQ) [ Time Frame: baseline to 24 months ]
  7. Pittsburgh Sleep Quality Index (PSQI) [ Time Frame: baseline to 24 months ]
  8. Saint-Antoine Pain Questionnaire (SAPQ) [ Time Frame: baseline to 24 months ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 60 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Diagnosis of fibromyalgia is clearly established by the criteria of the American College of Rheumatology (ACR).
  • Body Mass Index (BMI) between 18.5 and 24.9 kg / m² (normal weight at HAS).
  • Spontaneous pain intensity greater than 3/10 on a VAS. Pain triggered by palpation must be equal to or greater than 4/10 of the EVA.
  • Patients with a medical certificate to the sport.

Exclusion Criteria:

  • Systemic disease, whether or not, generating pain musculoskeletal
  • Heart disease, respiratory, endocrine, metabolic or neurological.
  • Patients and patient pregnant lactating or planning to become pregnant within 2 years.
  • Patients who have changed in the last 2 months any pharmacological treatment.
  • Patients taking drugs that affect the heart rate variability
  • Patients who have conditions that could affect the cortisol levels
  • Patients with a psychiatric diagnosis of schizophrenia, delusional disorder and other personality disorders
  • Patients taking substances affecting cortisol secretion

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02486965


Contacts
Layout table for location contacts
Contact: Celine BODERE, Doctor 0298347308 ext +33 cel.bodere@wanadoo.fr
Contact: Anais BONNABESSSE, Doctor 0610934368 ext +33 anais.bonnabesse@gmail.com

Locations
Layout table for location information
France
CHRU Brest Recruiting
Brest, France, 29200
Contact: Gildas L'HEVEDER, Doctor    0298347308 ext +33    gildas.lheveder@chu-brest.fr   
Contact: Céline BODERE, Doctor    0298016489 ext +33    celine.bodere@univ-brest.fr   
CHU Rennes Not yet recruiting
Rennes, France, 35033
Contact: François CARRE, Professor    0299284133    francois.carre@univ-rennes1.fr   
Sponsors and Collaborators
University Hospital, Brest
Investigators
Layout table for investigator information
Principal Investigator: Gildas L'HEVEDER, Doctor CHRU Brest

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: University Hospital, Brest
ClinicalTrials.gov Identifier: NCT02486965     History of Changes
Other Study ID Numbers: DOUFISPORT (RB 14.076)
First Posted: July 1, 2015    Key Record Dates
Last Update Posted: January 18, 2019
Last Verified: January 2019
Keywords provided by University Hospital, Brest:
VAS
thermode test
training program
6MWT
Additional relevant MeSH terms:
Layout table for MeSH terms
Fibromyalgia
Myofascial Pain Syndromes
Muscular Diseases
Musculoskeletal Diseases
Rheumatic Diseases
Neuromuscular Diseases
Nervous System Diseases